Thu, November 10, 2022
Wed, November 9, 2022
Tue, November 8, 2022
Mon, November 7, 2022

Puneet Souda Maintained (ABCL) at Buy with Increased Target to $20 on, Nov 9th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-20-on-nov-9th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Puneet Souda of SVB Leerink, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Increased Target from $13 to $20 on, Nov 9th, 2022.

Puneet has made no other calls on ABCL in the last 4 months.



There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Puneet's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Puneet


  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $34 on, Wednesday, August 10th, 2022
  • Do Kim of "Piper Sandler" Maintained at Buy with Increased Target to $22 on, Tuesday, July 26th, 2022

Publication Contributing Sources